RedChip TV Announces Lineup for This Week's Show on Fox

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg

ORLANDO, Fla., April 10, 2014 (GLOBE NEWSWIRE) -- RedChip Companies, Inc. ("RedChip"), an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money" television program will feature two emerging growth companies on Fox Business nationwide on Thursday, April 10, 2014 at 10:00 p.m. Pacific (1 a.m. EDT). The show will also air on Bloomberg U.K. Saturday, April 12, 2014 at 12:30 a.m. GMT; on Bloomberg Europe on Sunday, April 13, 2014 at 8:30 a.m. and 3:30 p.m. GMT; and on Bloomberg Asia on Sunday, April 13, 2014 at 3:30 p.m. HKT.

This week's show features interviews with Ray Akers, CEO of Akers Biosciences, Inc. (Nasdaq: AKER ), a leading designer and manufacturer of rapid diagnostic screening and testing products; Neil Warma, CEO of Opexa Therapeutics (Nasdaq: OPXA ), a biotechnology company developing Tcelna®, a novel T-cell immunotherapy for the treatment of multiple sclerosis (MS); Eric Kuby, Chief Investment Officer of North Star Investment Management Corporation.

Produced in RedChip's state-of-the-art studio in Orlando, "The RedChip Money Report: Small Stocks Big Money" delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies. The show is hosted by Dave Gentry, a leading authority on small-cap stocks and president of RedChip, an international small-cap research firm and an Inc. 5000 company. Mr. Gentry has made multiple guest appearances on both CNBC and Fox Business News and has been a consultant to hundreds of public companies.

To view this week's show online, click here: https://www.youtube.com/watch?v=NG2-ccXabD4 .

Individual guest segments from this week's show can be viewed at the following links:

AKER: http://www.redchip.com/company/home/AKER

OPXA: http://www.redchip.com/company/home/OPXA

North Star: https://www.youtube.com/watch?v=9fOwJl9CZkk

"The RedChip Money Report: Small Stocks Big Money"™ reaches 80 million homes on Fox Business and 139 million homes in more than 50 cities on Bloomberg Europe. The show reaches an additional 13.5 million homes in a dozen countries on Bloomberg Asia.

About RedChip Companies, Inc.

RedChip Companies, an Inc. 5000 company, is an international small-cap research, investor relations, and media company headquartered in Orlando, Florida; with affiliate offices in San Francisco, Pittsburgh, and Seoul. RedChip delivers concrete, measurable results for its clients through its extensive global network of small-cap institutional and retail investors. RedChip has developed the most comprehensive platform of products and services for small-cap companies, which includes: Research Reports, Retail and Institutional Marketing, Institutional and Retail Road Shows, Virtual CEO Conferences, an International TV show, The RedChip Money Report™, featuring small-cap companies, airing weekly on Fox Business, Bloomberg Europe, and Bloomberg Asia in over 200 million homes,  Shareholder Intelligence, Strategic Marketing, Crisis Management, Social Media, Blogging Services, and Webcasts. To learn more about RedChip's products and services, please visit: http://www.redchip.com/our_services

"Discovering Tomorrow's Blue Chips Today"™

Jon Cunningham RedChip Companies, Inc. Tel: 1-800-RED-CHIP (733-2447), ext. 107 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 179

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 107

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 311

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 245

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 200

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 477

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 0

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

LanzaJet Partners with Fluor for Innovative Sustainable Aviation Fuel Project

Updated Category News Views 255

LanzaJet Collaborates with Fluor Corporation for Project Speedbird CHICAGO — LanzaJet, Inc., a frontrunner in the sustainable fuels technology sector, has announced its partnership with Fluor Corporation for the Front-End Engineering and Design (FEED) of Project Speedbird. This cutting-edge initiative will focus on developing a commercial-scale ethanol-to-sustainable...

Continue Reading
Remarkable Gains of Pippin and AB Tokens Amid Crypto Losses

Updated Category News Views 117

Understanding the Cryptocurrency Market Disruptions In a tumultuous year for large-cap cryptocurrencies, many investors found themselves disheartened by the significant declines in values. However, amidst these struggles, two lesser-known tokens made an unexpected leap, capturing the financial world's attention with stunning performances. The Unprecedented Surge of Pippin...

Continue Reading
Celebrate Spring with Unforgettable Experiences at Grande Lakes

Updated Category News Views 198

Experience the Magic of Spring at Grande Lakes Orlando The changing of seasons brings a wonderful opportunity to celebrate, and there’s no better place to embrace the spirit of spring than at Grande Lakes Orlando. Nestled within a lush landscape, this expansive resort offers a perfect blend of adventure, relaxation, and luxury. Visitors can indulge in a variety of...

Continue Reading
NASA's SpaceX Crew-9 Astronauts Share Insights from Space Mission

Updated Category News Views 365

NASA's SpaceX Crew-9 Astronauts Share Mission Insights After an extensive mission aboard the International Space Station (ISS), the NASA astronauts from the SpaceX Crew-9 will gather for a post-flight news conference. The event is set to offer a unique opportunity to delve into the rich scientific endeavors undertaken during their extraordinary stay in space. The...

Continue Reading
Essity Achieves EcoVadis Platinum Medal for Sustainability Excellence

Updated Category News Views 167

Essity Recognized for Sustainability Leadership Essity, a global leader in hygiene and health solutions, has been awarded the prestigious Platinum medal by EcoVadis for its outstanding performance in sustainability. This achievement places the company in the top 1% of all assessed companies worldwide, reflecting its dedication to responsible business practices. Strong...

Continue Reading